New registry to monitor fabry drug safety in pregnant women and newborns
NCT ID NCT06941025
First seen Apr 05, 2026 · Last updated May 21, 2026 · Updated 7 times
Summary
This study is a worldwide registry that will follow about 10 women with Fabry disease who received the drug pegunigalsidase alfa around the time of pregnancy or while breastfeeding. Researchers will track pregnancy outcomes and infant health for up to one year after birth. The goal is to better understand the safety of this treatment for both mothers and babies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No physical study sites - Decentralized, web-based registry
RECRUITINGWashington D.C., District of Columbia, 20001, United States
-
No physical study sites - Decentralized, web-based registry
RECRUITINGBerlin, Germany
-
No physical study sites - Decentralized, web-based registry
RECRUITINGRome, Italy
-
No physical study sites - Decentralized, web-based registry
RECRUITINGMadrid, Spain
-
No physical study sites - Decentralized, web-based registry
NOT_YET_RECRUITINGLondon, United Kingdom
Conditions
Explore the condition pages connected to this study.